Blood Test Study Predicts Premature Birth Outcomes
Introduction to the Research
A recent study published in the journal Science explores the potential of a simple blood test to predict the outcomes associated with premature births. Traditionally, ultrasound has been the preferred method for determining a baby’s gestational age. However, this approach can be costly, particularly in lower-income regions, and it does not effectively predict spontaneous premature births, which remain a significant contributor to neonatal mortality and long-term complications in the United States.
Limitations of Current Methods
The mother’s last menstrual period has also been used to estimate gestational age. However, this method is often inaccurate, as many women may not remember the exact date. Inaccurate dating can lead to unnecessary medical interventions, such as labor induction and cesarean sections. Therefore, finding a more economical and effective way to determine gestational age while assessing the risk of premature birth is essential.
Current Blood Test Indicators
Currently, human chorionic gonadotropin (HCG) is utilized to confirm pregnancy, and alpha-fetoprotein is monitored for pregnancy complications. However, these biomarkers in maternal blood do not provide information on the gestational age of the fetus.
Study Details and Findings
Researchers conducted a study involving women from Denmark, Alabama, and Pennsylvania to investigate if maternal blood tests could effectively measure gestational age and predict premature births. The initial phase of the study analyzed 521 blood samples from 31 pregnant women in Denmark, all of whom delivered at full term (37 weeks or more). The findings were consistent with previous studies that relied on ultrasound and the last menstrual period for gestational age predictions.
To assess the ability to predict premature births, the researchers examined two additional groups in the United States, comprising 15 women from the University of Pennsylvania and 23 from the University of Alabama at Birmingham, all possessing known risk factors for premature delivery. Unfortunately, the researchers reported an inability to predict the delivery timing for premature births, despite successfully forecasting outcomes for full-term pregnancies.
Study Limitations and Future Directions
The study faced limitations, notably the lack of blinding, which likely introduced researcher bias. For the findings to be utilized as a diagnostic or screening tool, it is crucial to involve a larger, more diverse sample size that includes various ethnic groups. The pilot study included one cohort of Caucasian women and two cohorts of African-American women.
Conclusion
In summary, maternal blood tests show promise in predicting gestational age and identifying women at risk for premature births. These tests could offer a more cost-effective alternative to ultrasound and have the potential for broader application in the general population.
Reference
Ngo, T., Moufarrej, M., Rasmussen, M., Camunas-Soler, J., Pan, W., & Okamoto, J. et al. (2018). Non-invasive blood tests for fetal development predict gestational age and preterm delivery. Science, 360(6393), 1133-1136. doi: 10.1126/science.aar3819